Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GHL
2276
DELISTED
Greenhill & Co., Inc.
GHL
| $2.98M | ﹤0.01% |
298,321
-28,867
| -9% | -$285K |
|
2277
The RMR Group
RMR
$325M
| $2.97M | ﹤0.01% |
100,694
+5,036
| +5% | +$146K |
|
2278
Bally's
BALY
$682M
| $2.94M | ﹤0.01% |
131,885
+5,830
| +5% | +$103K |
|
2279
National CineMedia
NCMI
$376M
| $2.93M | ﹤0.01% |
98,757
+1,533
| +2% | +$46.1K |
|
2280
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.1B
| $2.92M | ﹤0.01% |
95,112
-30,730
| -24% | -$943K |
|
2281
Liberty Energy
LBRT
$3.05B
| $2.92M | ﹤0.01% |
532,172
+119,544
| +29% | +$561K |
|
|
COWN
2282
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $2.92M | ﹤0.01% |
179,868
+2,444
| +1% | +$29.6K |
|
|
ATRS
2283
DELISTED
Antares Pharma, Inc.
ATRS
| $2.92M | ﹤0.01% |
1,059,890
+93,426
| +10% | +$261K |
|
2284
Great Southern Bancorp
GSBC
$874M
| $2.91M | ﹤0.01% |
72,179
+3,804
| +6% | +$150K |
|
|
XENT
2285
DELISTED
Intersect ENT, Inc
XENT
| $2.91M | ﹤0.01% |
214,616
+20,411
| +11% | +$237K |
|
|
HTBK
2286
DELISTED
Heritage Commerce
HTBK
| $2.9M | ﹤0.01% |
386,905
+20,833
| +6% | +$163K |
|
2287
LeMaitre Vascular
LMAT
$2.32B
| $2.87M | ﹤0.01% |
108,851
+5,754
| +6% | +$150K |
|
2288
Impinj
PI
$4.62B
| $2.87M | ﹤0.01% |
104,621
+6,100
| +6% | +$143K |
|
2289
Arcos Dorados Holdings
ARCO
$1.72B
| $2.87M | ﹤0.01% |
703,994
-123,719
| -15% | -$462K |
|
|
CBPO
2290
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $2.86M | ﹤0.01% |
28,005
-3,877
| -12% | -$415K |
|
2291
FB Financial Corp
FBK
$3.02B
| $2.86M | ﹤0.01% |
115,450
+8,538
| +8% | +$190K |
|
2292
Arrow Financial
AROW
$659M
| $2.85M | ﹤0.01% |
107,676
+7,155
| +7% | +$175K |
|
2293
Q32 Bio
QTTB
$466M
| $2.84M | ﹤0.01% |
10,394
+1,826
| +21% | +$487K |
|
2294
Quanterix
QTRX
$164M
| $2.84M | ﹤0.01% |
103,613
+16,725
| +19% | +$423K |
|
|
AXDX
2295
DELISTED
Accelerate Diagnostics
AXDX
| $2.82M | ﹤0.01% |
18,613
+1,905
| +11% | +$188K |
|
|
KBAL
2296
DELISTED
Kimball International
KBAL
| $2.8M | ﹤0.01% |
242,377
+15,541
| +7% | +$177K |
|
2297
Marcus Corp
MCS
$897M
| $2.8M | ﹤0.01% |
210,762
+45,823
| +28% | +$614K |
|
|
BFS
2298
Saul Centers
BFS
$836M
| $2.79M | ﹤0.01% |
86,438
+11,999
| +16% | +$383K |
|
|
SRNE
2299
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $2.78M | ﹤0.01% |
442,623
+117,131
| +36% | +$448K |
|
|
MRSN
2300
DELISTED
Mersana Therapeutics
MRSN
| $2.78M | ﹤0.01% |
4,748
+1,304
| +38% | +$445K |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.